Alex Carchidi

Writer, consultant, and entrepreneur. Motley Fool contributor.

[Alex Carchidi @AlexCarchidi]

Here's my high-level take on what's going on in crypto right now:

https://t.co/TP1wGpzJJb

[Alex Carchidi @AlexCarchidi]

Check out my latest article for Quantum Canary about the intersection of ZK and quantum computing:

https://t.co/zXVuZwlBu7

[Alex Carchidi @AlexCarchidi]

@SmallCapBob2 Tell me what you really think 😂

In all seriousness, I think NVAX has a great COVID vaccine product -- the best so far based on the data I've seen. But the longstanding manufacturing issues were resolved so late in the game that they missed the window to be a good investment.

[Alex Carchidi @AlexCarchidi]

@KingFranklinIV I'd attend!

[Alex Carchidi @AlexCarchidi]

@ira_knee So in your view, the misconduct allegations are fabricated, and CUNY's investigation is bogus? I'm struggling to understand what investors see in this company

[Alex Carchidi @AlexCarchidi]

@Jettyjittyjit Hi Jason -- the EPS figures are just the average analyst estimates which haven't been proven true or false yet, as they're for future years, whereas the PE figure is based on net income from the last 12 months. It has trailing 12-month EPS of $0.56.

[Alex Carchidi @AlexCarchidi]

@Biohazard3737 I'd join.

[Alex Carchidi @AlexCarchidi]

@BoldJava Glad you liked it! More to come.

[Alex Carchidi @AlexCarchidi]

@badri_kannan Glad you liked it! I'm still salty about it because I wish I hadn't sold

[Alex Carchidi @AlexCarchidi]

I recently went on the @SeekingAlpha Cannabis Investing Podcast to discuss the state of the psychedelics industry, check it out: https://t.co/W9mvdz4hRl $CYBN $ATAI $CMPS $SEEL

[Alex Carchidi @AlexCarchidi]

@ClicksAndHisses I agree with you; this stuff never happens with reputable companies. But, I didn't want to get into the weeds of the issue in the article because I felt that it might be confusing for readers.

If you can think of a pithy way to describe what happened, I'm all ears.

[unusual_whales @unusual_whales]

Last week, Costco, $COST, CFO Richard Galant has said that its hot dog-and-soda combo at its stores will stay at $1.50, despite months of decades-high inflation.

[Alex Carchidi @AlexCarchidi]

@BritGeo @DeepakChopra Congratulations!!!

[Alex Carchidi @AlexCarchidi]

Anyone have any thoughts on reading the Economist versus the Financial Times?

Wondering whether to renew my Economist subscription.

[Alex Carchidi @AlexCarchidi]

@EddyElfenbein Uruguay. It's expensive, but they have attained their slice of peace on Earth.

[Alex Carchidi @AlexCarchidi]

Going to be publishing a few inflation-related articles soon.

If anyone has any specific suggestions for angles they'd like to see, let me know!

[Alex Carchidi @AlexCarchidi]

@LotInLifeProd @RobertB09461202 Hopefully I'm wrong and they do actually submit for EUA this month, but they've set similar deadlines and missed them more than once before.

As of October they were still dealing with purity issues, so we'll see if a month or so is enough to sort things out.

[Alex Carchidi @AlexCarchidi]

@lundgren7 Hi, this article https://t.co/2lG98aXWJc elaborates on some of what is going on.

My operative word here is "might" -- I'd love to see Novavax submit their filing promptly and get regulatory approval before 2022, but they've been optimistic (and then announced delays) before.

[Alex Carchidi @AlexCarchidi]

@Viscount_1 Hi, here is a good general recap: https://t.co/2lG98aXWJc. I would stress that the problem here is the repeated nature of various manufacturing issues in general rather than any specific obstacles with purity. I'm confident that Novavax will figure things out in due time.